We are live on
!
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$88M
1-Year Est. Return
48.84%
This Fund
S&P 500
This Quarter
Est. Return
-4.28%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$27.9M
AUM Growth
+$12.7M
(+84%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
43.59%
Top 10 Holdings %
Top 10 Hldgs %
17.59%
Holding
150
New
90
Increased
7
Reduced
6
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INSY
Insys Therapeutics, Inc.
INSY
|
+$637K |
| 2 |
Live Nation Entertainment
LYV
|
+$625K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$462K |
| 4 |
Western Alliance Bancorporation
WAL
|
+$461K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$460K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$519K |
| 2 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$510K |
| 3 |
ESPR
Esperion Therapeutics
ESPR
|
+$443K |
| 4 |
Murphy USA
MUSA
|
+$440K |
| 5 |
DGI
DigitalGlobe Inc.
DGI
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Consumer Discretionary | 13.09% |
| 3 | Healthcare | 12.68% |
| 4 | Industrials | 11.61% |
| 5 | Financials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Accenture
ACN
$106B
| $339K | 1.22% |
+2,932
| New | +$301K |
|
27
Opko Health
OPK
$1.02B
| $336K | 1.2% |
+32,350
| New | +$296K |
|
|
PEGI
28
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $310K | 1.11% |
16,238
+5,597
| +53% | +$101K |
|
|
CHMT
29
DELISTED
Chemtura Corporation
CHMT
| $310K | 1.11% |
+11,748
| New | +$300K |
|
|
EMWP
30
DELISTED
Eros Media World PLC
EMWP
| $308K | 1.1% |
1,338
-1,105
| -45% | -$189K |
|
|
LOGM
31
DELISTED
LogMein, Inc.
LOGM
| $301K | 1.08% |
+5,959
| New | +$307K |
|
|
NATI
32
DELISTED
National Instruments Corp
NATI
| $296K | 1.06% |
+9,827
| New | +$282K |
|
|
IBKC
33
DELISTED
IBERIABANK Corp
IBKC
| $296K | 1.06% |
+5,767
| New | +$283K |
|
34
Viasat
VSAT
$9.67B
| $293K | 1.05% |
+3,989
| New | +$265K |
|
|
ESL
35
DELISTED
Esterline Technologies
ESL
| $292K | 1.05% |
+4,554
| New | +$300K |
|
|
QGENF
36
DELISTED
QIAGEN NV
QGENF
| $276K | 0.99% |
+12,334
| New | +$276K |
|
37
World Kinect Corp
WKC
$2.06B
| $272K | 0.98% |
+5,605
| New | +$240K |
|
38
Lincoln National
LNC
$7.92B
| $270K | 0.97% |
+6,897
| New | +$269K |
|
39
Fortinet
FTNT
$112B
| $267K | 0.96% |
+43,620
| New | +$241K |
|
40
Zurn Elkay Water Solutions
ZWS
$8.55B
| $264K | 0.95% |
+27,071
| New | +$230K |
|
41
Gaming and Leisure Properties
GLPI
$13B
| $261K | 0.94% |
+8,452
| New | +$229K |
|
42
Cabot Corp
CBT
$4.72B
| $260K | 0.93% |
+5,389
| New | +$232K |
|
43
SLM Corp
SLM
$4.83B
| $258K | 0.93% |
40,541
+18,928
| +88% | +$114K |
|
44
Woodward
WWD
$23B
| $257K | 0.92% |
+4,942
| New | +$236K |
|
45
Norwegian Cruise Line
NCLH
$9.53B
| $255K | 0.91% |
+4,611
| New | +$222K |
|
46
ACI Worldwide
ACIW
$6.12B
| $254K | 0.91% |
+12,238
| New | +$230K |
|
|
TSRO
47
DELISTED
TESARO, Inc.
TSRO
| $251K | 0.9% |
+5,711
| New | +$229K |
|
|
IHS
48
DELISTED
IHS INC CL-A COM STK
IHS
| $250K | 0.9% |
2,012
+81
| +4% | +$8.63K |
|
|
MIC
49
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $248K | 0.89% |
+3,678
| New | +$233K |
|
50
Puma Biotechnology
PBYI
$398M
| $244K | 0.87% |
+8,298
| New | +$375K |
|
Similar funds
BCP
PBCM
CVM
XXIP
DG
RFL
IAP
MPEM
Parametrica Management's Q1 2016 Portfolio in Review
As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.
- Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
- Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
- Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
- Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
- Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
- Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
- Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.
Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.